News Lantheus Holdings, Inc.

Equities

LNTH

US5165441032

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
62.33 ^USD	+1.38%		+1.35%	+0.53%

Apr. 18	B. Riley Raises Price Target on Lantheus Holdings to $99 From $95, Keeps Buy Rating	MT
Mar. 07	Lantheus Holdings Insider Sold Shares Worth $262,005, According to a Recent SEC Filing	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

B. Riley Raises Price Target on Lantheus Holdings to $99 From $95, Keeps Buy Rating	Apr. 18	MT
Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time	Apr. 18	AQ
Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time	Apr. 18	GL
Lantheus Holdings Insider Sold Shares Worth $262,005, According to a Recent SEC Filing	Mar. 07	MT
Perspective Therapeutics, Inc. announced that it has received $87.409482 million in funding from Lantheus Holdings, Inc. and other investors	Mar. 05	CI
Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024	Mar. 05	GL
Lantheus Holdings Says FDA Approves Expanded Use of Definity in Pediatric Patients	Mar. 04	MT
Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients	Mar. 04	GL
Lantheus Holdings, Inc. Announces the FDA Approval of Definity (Perflutren Lipid Microsphere) for Pediatric Patients	Mar. 04	CI
Perspective Therapeutics, Inc. announced that it expects to receive $87.409482 million in funding from Lantheus Holdings, Inc. and other investors	Mar. 03	CI
Lantheus Names Amanda Morgan Chief Commercial Officer	Feb. 28	MT
Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer	Feb. 28	GL
Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer	Feb. 28	AQ
Truist Adjusts Price Target on Lantheus Holdings to $82 From $80, Maintains Buy Rating	Feb. 26	MT
Lantheus to Present at the TD Cowen 44th Annual Health Care Conference	Feb. 26	GL
Sector Update: Health Care Stocks Advance Pre-Bell Thursday	Feb. 22	MT
Lantheus Holdings Q4 Adjusted Earnings, Revenue Climb; Issues Q1, Full Year Guidance; Shares Rise	Feb. 22	MT
Transcript : Lantheus Holdings, Inc., Q4 2023 Earnings Call, Feb 22, 2024	Feb. 22
Lantheus Holdings: Q4 Earnings Snapshot	Feb. 22	AQ
(LNTH) LANTHEUS HOLDINGS Forecasts Q1 EPS Range $1.50 - $1.54	Feb. 22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Lantheus Holdings, Inc.

Equities

LNTH

US5165441032

Summary

Filters